A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(22 sites)

United States

Research Site 7, Park Ridge, Illinois

Research Site 2, New York, New York

Research Site 1, Cincinnati, Ohio

Research Site 14, Pittsburgh, Pennsylvania

Australia

Research Site 13, Camperdown, New South Wales

Research Site 9, Saint Leonards, New South Wales

Research Site 21, Heidelberg, Victoria

Research Site 3, Nedlands, Western Australia

Canada

Research Site 5, Vancouver, British Columbia

Research Site 6, Chicoutimi, Quebec

Research Site 4, Québec, Quebec

Georgia

Research Site 17, Tbilisi

Research Site 18, Tbilisi

Research Site 19, Tbilisi

Israel

Research Site 10, Jerusalem

Research Site 15, Tel Litwinsky

Japan

Research Site 16, Okayama, Okayama-ken

Research Site 20, Fukushima

Research Site 22, Saitama

New Zealand

Research Site 12, Christchurch

South Africa

Research Site 11, Parktown, Johannesburg

Research Site 8, Cape Town